People living with HIV face a greater risk of developing lung diseases at a much younger age, even if they have never smoked.

Researchers found that certain immune cells, genes, and the drug metformin may help keep HIV dormant after treatment stops, ...

The introduction of HAART for HIV has coincided with a syphilis resurgence, suggesting unintended public health trade-offs ...

In a study presented at ESCMID Global, a biological clock showed ART slows down the accelerated aging in people with HIV by ...

HIV care is no longer just about viral suppression — it’s about future-proofing patient health, reducing long-term risk and creating a more sustainable healthcare system.

Researchers at Case Western Reserve University’s Frances Payne Bolton School of Nursing will assess the effectiveness of palliative care home health visits in treating people with HIV and other ...

Systems approaches, including omics and machine learning, offer holistic insights into atherosclerosis mechanisms, surpassing traditional hypothesis testing. Chronic kidney disease and HIV infection ...

The dissonance between medical success in treating HIV and social acceptance of people living with HIV must be addressed ...

Bristol-Myers Squibb today announced that the European Commission has approved the expanded use of Daklinza ® (daclatasvir), a first-in-class oral, once-a-day pill used in combination with other ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...